Eli Lilly & Co. v. Barr Laboratories, Inc.

534 U.S. 1109, 122 S. Ct. 913, 151 L. Ed. 2d 879, 70 U.S.L.W. 3443, 2002 U.S. LEXIS 480
CourtSupreme Court of the United States
DecidedJanuary 14, 2002
DocketNo. 01-660
StatusPublished

This text of 534 U.S. 1109 (Eli Lilly & Co. v. Barr Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eli Lilly & Co. v. Barr Laboratories, Inc., 534 U.S. 1109, 122 S. Ct. 913, 151 L. Ed. 2d 879, 70 U.S.L.W. 3443, 2002 U.S. LEXIS 480 (2002).

Opinion

C. A. Fed. Cir. Motions of Biotechnology Industry Organization et al. and Intellectual Property Owners Association for leave to file briefs as amici curiae granted. Certiorari denied.

Justice O’Connor took no part in the consideration or decision of these motions and this petition.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
534 U.S. 1109, 122 S. Ct. 913, 151 L. Ed. 2d 879, 70 U.S.L.W. 3443, 2002 U.S. LEXIS 480, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eli-lilly-co-v-barr-laboratories-inc-scotus-2002.